Pfizer cuts revenue forecast as supply snags, dollar strength weigh

Pfizer cuts revenue forecast as supply snags, dollar strength weigh


U.S. drugmaker Pfizer Inc's third-quarter profit rose nearly 45 percent, driven by lower tax rates and higher sales of breast cancer drug Ibrance and pneumonia vaccine Prevnar. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca, Mexico October 1, 2018.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога